GMED insider transaction filings
GLOBUS MEDICAL INC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-16. Screen GMED transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 3 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings by 2 insiders — 55,000 shares, $4,413,467 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 30,000 shares @ $74.58 ($2,237,502) by TOBIN JAMES R, filed 2026-09-16.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| TOBIN JAMES R — Director | 1 | — | 1 leg · 30,000 sh · $2,237,502 | 4 |
| ZARRILLI STEPHEN T — Director | 1 | — | 1 leg · 25,000 sh · $2,175,965 | 2 |
| Davidar David D — Director | 1 | — | — | 1 |
Recent Form 4 filings — GLOBUS MEDICAL INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | TOBIN JAMES R — Director | Option exercise (M): 15,000 @ $53.75 · Option exercise (M): 15,000 @ $63.68 · Sale (S): 30,000 @ $74.58 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | ZARRILLI STEPHEN T — Director | Option exercise (M): 25,000 @ $53.27 · Sale (S): 25,000 @ $87.04 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Davidar David D — Director | Gift (G): 2,500 @ $0 | EDGAR |
| 2026-06-09 | 4 | Davidar David D — Director | Option exercise (M): 25,000 @ $26.27 · Sale (S): 25,000 @ $80.76 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | RHOADS ANN D — Director | Option exercise (M): 25,000 @ $26.27 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Huller Kelly — EVP, GC, Corporate Secretary | Option exercise (M): 20,000 @ $43.58 · Sale (S): 20,000 @ $94.50 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Huller Kelly — EVP, GC, Corporate Secretary | Option exercise (M): 10,000 @ $45.64 · Sale (S): 10,000 @ $87.67 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Norwalk Leslie V — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Pfeil Keith W — President, CEO, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Kline Kyle — Senior Vice President, CFO | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Paul David C — Executive Chairman, Director, 10% owner | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Douglas Robert Andrew — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Lemaitre Dan — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | RHOADS ANN D — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | DeFord John A — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Wolterman Dan — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Davidar David D — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Huller Kelly — EVP, GC, Corporate Secretary | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | ZARRILLI STEPHEN T — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | TOBIN JAMES R — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4/A | Kline Kyle — Senior Vice President, CFO | Option exercise (M): 4,896 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Kline Kyle — Senior Vice President, CFO | Option exercise (M): 3,594 @ $51.87 · Sale (S): 3,594 @ $101.10 · Option exercise (M): 3,594 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Norwalk Leslie V — Director | Sale (S): 2,000 @ $101.10 | EDGAR |
| 2026-01-05 | 4 | Davidar David D — Director | Gift (G): 6,100 @ $0 | EDGAR |
| 2025-12-16 | 4 | Norwalk Leslie V — Director | Sale (S): 4,000 @ $88.85 | EDGAR |
| 2025-12-10 | 4 | Paul David C — Executive Chairman, Director, 10% owner | Option exercise (M): 34,375 @ $25.52 · Option exercise (M): 34,375 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Kline Kyle — Senior Vice President, CFO | Option exercise (M): 3,646 @ $53.14 · Option exercise (M): 5,000 @ $56.43 · Option exercise (M): 5,000 @ $64.44 · Option exercise (M): 4,896 @ $63.68 · Sale (S): 18,542 @ $90 · Option exercise (M): 3,646 (derivative) @ $0 · +3 more | EDGAR |
| 2025-11-28 | 4 | Huller Kelly — SVP, GC, Corporate Secretary | Option exercise (M): 7,500 @ $25.96 · Sale (S): 7,500 @ $90 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Davidar David D — Director | Option exercise (M): 25,000 @ $25.52 · Sale (S): 25,000 @ $86.00 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | ZARRILLI STEPHEN T — Director | Option exercise (M): 25,000 @ $44.14 · Sale (S): 25,000 @ $84.29 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | RHOADS ANN D — Director | Sale (S): 8,000 @ $81 · Sale (S): 2,000 @ $85 | EDGAR |
| 2025-09-16 | 4 | RHOADS ANN D — Director | Sale (S): 10,000 @ $58.46 | EDGAR |
| 2025-08-27 | 4 | Pfeil Keith W — President, CEO, Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Kline Kyle — Senior Vice President, CFO | Grant/award (A): 20,909 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Davidar David D — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | DeFord John A — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Douglas Robert Andrew — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Huller Kelly — SVP, GC, Corporate Secretary | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Lemaitre Dan — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Norwalk Leslie V — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Paul David C — Executive Chairman, Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Pfeil Keith W — COO, CFO | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | RHOADS ANN D — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Scavilla Daniel T — President, CEO, Director | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Wolterman Dan — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | ZARRILLI STEPHEN T — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | TOBIN JAMES R — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | RHOADS ANN D — Director | Sale (S): 7,500 @ $78.68 | EDGAR |
| 2025-01-14 | 4 | Pfeil Keith W — COO, CFO | Option exercise (M): 5,833 @ $49.65 · Option exercise (M): 8,334 @ $53.27 · Sale (S): 12,501 @ $88.17 · Sale (S): 1,666 @ $89.17 · Option exercise (M): 5,833 (derivative) @ $0 · Option exercise (M): 8,334 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Huller Kelly — SVP, GC, Corporate Secretary | Option exercise (M): 2,500 @ $24.21 · Sale (S): 2,500 @ $87.00 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — GLOBUS MEDICAL INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-21 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GMED returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →